80
Participants
Start Date
April 13, 2022
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Kennedy Krieger Institute, Baltimore
Virginia Commonwealth University, Richmond
Nationwide Children's Hospital, Columbus
University of Iowa, Iowa City
University of Minnesota, Minneapolis
Washington University School of Medicine, St Louis
University of Kansas Medical Center, Kansas City
University of Colorado Anschutz Medical Campus, Aurora
University of California, Irvine, Orange
University of Auckland, Auckland
John Walton Muscular Dystrophy Research Centre, Newcastle upon Tyne
Collaborators (1)
Edgewise Therapeutics, Inc.
INDUSTRY
Virginia Commonwealth University
OTHER